These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

78 related items for PubMed ID: 8205596

  • 21.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 22. Comparisons of rosiglitazone versus pioglitazone monotherapy introduction and associated health care utilization in Medicaid-enrolled patients with type 2 diabetes mellitus.
    Balkrishnan R, Arondekar BV, Camacho FT, Shenolikar RA, Horblyuk R, Anderson RT.
    Clin Ther; 2007 Jun; 29(6 Pt 1):1306-15. PubMed ID: 18036392
    [Abstract] [Full Text] [Related]

  • 23. Helicobacter pylori eradication and standardized 3-month omeprazole therapy in functional dyspepsia.
    Koskenpato J, Farkkilä M, Sipponen P.
    Am J Gastroenterol; 2001 Oct; 96(10):2866-72. PubMed ID: 11693319
    [Abstract] [Full Text] [Related]

  • 24.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 25. Outpatient cancer drug costs: changes, drivers, and the future.
    Halbert RJ, Zaher C, Wade S, Malin J, Lawless GD, Dubois RW.
    Cancer; 2002 Feb 15; 94(4):1142-50. PubMed ID: 11920485
    [Abstract] [Full Text] [Related]

  • 26.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 27. Use of H2-receptor antagonists in patients with dyspepsia and heartburn: a cost comparison.
    Goulston KJ, Dent OF, Mant A, Logan J, Ngu M.
    Med J Aust; 1991 Jul 01; 155(1):20-6. PubMed ID: 1676825
    [Abstract] [Full Text] [Related]

  • 28. Switching the histamine H2 receptor antagonist famotidine to nonprescription status in Canada. An economic evaluation.
    Tasch RF, Goeree R, Henke CJ, O'Brien BJ.
    Pharmacoeconomics; 1996 Jan 01; 9(1):61-75. PubMed ID: 10160088
    [Abstract] [Full Text] [Related]

  • 29. Policy analysis of the conversion of histamine2 antagonists to over-the-counter use.
    Kalish SC, Bohn RL, Avorn J.
    Med Care; 1997 Jan 01; 35(1):32-48. PubMed ID: 8998201
    [Abstract] [Full Text] [Related]

  • 30. NICE issues guidance for heartburn and indigestion.
    Ferriman A.
    BMJ; 2000 Jul 22; 321(7255):197. PubMed ID: 10903645
    [No Abstract] [Full Text] [Related]

  • 31. On call. I have heartburn a few times a month. My doctor suggested I use a generic H₂blocker like famotidine or ranitidine. Is this better than an antacid?
    Kormos W.
    Harv Mens Health Watch; 2014 Feb 22; 18(7):2. PubMed ID: 24818285
    [No Abstract] [Full Text] [Related]

  • 32. Antiulcer prescribing program in a state correctional system.
    Keith MR, Cason DM, Helling DK.
    Ann Pharmacother; 1994 Jun 22; 28(6):792-6. PubMed ID: 7919571
    [Abstract] [Full Text] [Related]

  • 33.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 34.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 35.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 36. [The combination of contact anesthetic and antacid in the therapy of heartburn during pregnancy].
    Brunclik V, Privrel T.
    Schweiz Rundsch Med Prax; 1988 May 24; 77(21):587-91. PubMed ID: 3387751
    [No Abstract] [Full Text] [Related]

  • 37.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 38.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 39. Heartburn in consumer-directed health care and the cost outcomes of therapeutic maximum allowable cost.
    Curtiss FR.
    J Manag Care Pharm; 2006 Jun 24; 12(5):402-5; 405. PubMed ID: 16792448
    [Abstract] [Full Text] [Related]

  • 40.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 4.